Aktiesnakken — November 2009
-
men jeg tror der er massivt short salg i den
-
læste at nogen havde svært ved at levere aktierne
-
hya det amerikanske biotek indeks er steget 33% i år genmab er faldet 66%
-
stinker, så er der jo nogle andre der skal købe dem op
-
bliver du fibonacci agtig
-
men vel ikke for gsk? hvis de pønser på at overtage biksen?
-
ja Hrmunk, analytikerne er virkeligt vendt på en tallerken og Genmab hjælper dem ikke så meget
-
de er først lige gået i gang....men der skal jo en del igennem
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind